Shireene Ratna Vethakkan

Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus

Lee Lee Lai, Shireene Ratna Vethakkan, Nik Raihan Nik Mustapha et al. · Digestive Diseases and Sciences · 2019 · 186 citations

Medicine, Internal Medicine, Pharmacology +12

Screening for non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography

Lee Lee Lai, Wan Nur Illyana Wan Yusoff, Shireene Ratna Vethakkan et al. · Journal of Gastroenterology and Hepatology · 2018 · 105 citations

Medicine, Internal Medicine, Pathology +16

Why do some people with type 2 diabetes who are using insulin have poor glycaemic control? A qualitative study

Wen Ting Tong, Shireene Ratna Vethakkan, Chirk Jenn Ng · BMJ Open · 2015 · 82 citations · Full text

Medicine, Health Sciences, Chronic Illness Self-management +14

Non‐alcoholic fatty liver disease in diabetics – prevalence and predictive factors in a multiracial hospital clinic population in <scp>M</scp>alaysia

Wah‐Kheong Chan, Alexander Tong Boon Tan, Shireene Ratna Vethakkan et al. · Journal of Gastroenterology and Hepatology · 2013 · 79 citations

Medicine, Internal Medicine, Nutritional Sciences +13

Continuous glucose monitoring results in lower HbA_1c in Malaysian women with insulin‐treated gestational diabetes: a randomized controlled trial

Sharmila Paramasivam, Karuthan Chinna, Awadhesh Kumar Singh et al. · Diabetic Medicine · 2018 · 68 citations

Medicine, Endocrinology, Maternal Health +17